Pharma association denies pandemic lobbying: "Interest protection was on standby"
Though a new report points to increased pharma lobbying during the pandemic, a Danish trade association says public and private actors came together to solve the crisis in Denmark.
by ulrich quistgaard, translated by daniel pedersen
When the Covid-19 pandemic made its way around the world, European policymakers, facing an acute need for vaccines, buckled under lobbying efforts, leading to higher prices and less transparency, a new report concludes.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Pfizer to quadruple Covid-19 vaccine price in US
For subscribers
